This content is PDF only. Please click on the PDF icon to access.
Rabies antiserum (equine origin) for use in the treatment of human rabies has been in short supply for 2 years but is now available from the manufacturer in adequate quantities. The many inquiries received from health departments and practitioners in recent weeks suggest that local stocks of this biological have not been replenished. Rabies antiserum is manufactured only by Lederle Laboratories. This manufacturer has provided a list of distribution points, all of which currently stock rabies antiserum. Since this passive antibody product is most effective when administered as soon after exposure as possible, it is recommended that potential users review
Rabies Antiserum Availability. Ann Intern Med. 1973;78:97–98. doi: https://doi.org/10.7326/0003-4819-78-1-97_2
Download citation file:
Published: Ann Intern Med. 1973;78(1):97-98.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use